Akebia Therapeutics, Inc.【AKBA】 業績推移・財務諸表

(単位:千ドル) 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 4Q16 1Q17 2Q17 3Q17 4Q17 1Q18 2Q18 3Q18 4Q18 1Q19 2Q19 3Q19 4Q19 1Q20 2Q20 3Q20 4Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 - - - - - - - - - - - - - - - - - 48,793 53,169 - 72,666 100,803 91,977 - 88,478 90,142 59,988 - 52,304 52,913 48,756 61,699 126,759 48,964 40,127 56,376 42,046 32,607 43,648 37,428 57,336
売上成長率(%) - - - - - - - - - - - - - - - - - - - - - - -
売上原価 - - - - - - - - - - - - - - - - - - - 7,768 31,257 37,669 38,263 38,147 27,713 174,616 30,345 63,234 34,606 52,495 15,944 31,344 18,600 37,947 19,484 17,284 18,009 11,605 17,047 14,161 7,625
研究開発費 6,157 5,524 6,648 - 7,505 7,182 15,790 - 20,235 30,877 31,238 - 60,049 43,751 58,711 - 61,404 71,917 70,634 - 82,351 85,694 74,512 - 81,231 52,819 46,857 - 40,611 37,214 40,471 43,833 26,027 27,350 19,686 20,197 13,330 9,731 7,647 8,487 9,754
販売管理費 - - - - - - - - - - - - - - - - - - - - 34,291 36,068 34,178 - 37,983 35,482 40,171 - 41,328 41,651 46,357 44,327 32,807 30,918 25,221 27,036 22,710 25,438 26,917 26,516 25,742
営業費用 9,909 7,839 9,584 10,607 10,896 10,889 19,678 20,050 26,046 36,188 36,182 39,579 65,837 50,656 65,459 75,949 70,428 84,455 81,012 142,240 117,378 122,657 109,619 126,299 119,890 89,345 87,738 78,868 82,634 79,759 87,698 88,848 74,257 59,191 45,581 48,088 37,073 35,938 35,326 35,772 36,197
営業利益 -9,910 -7,840 -9,584 -10,607 -10,896 -10,889 -19,678 -20,050 -26,046 -36,188 -36,182 -38,044 -44,972 -22,136 -24,176 11,367 -24,498 -35,662 -27,843 -90,158 -75,969 -59,523 -55,905 -94,891 -59,125 -173,819 -58,095 -85,403 -64,936 -79,341 -54,886 -58,493 33,902 -48,174 -24,938 -8,996 -13,036 -14,936 -8,725 -12,505 13,514
営業利益率 (%) - - - - - - - - - - - - - - - - - - - -
経常(税引前)利益 - - - - - - - - - - - - - - - - - - - - -75,178 -59,015 -55,862 - -60,747 -175,751 -59,959 - - - - - - - - - - -17,985 -8,582 -20,039 6,112
経常(税引前)利益率(%) - - - - - - - - - - - - - - - - - - - - -103.46 -58.54 -60.73 - -68.66 -194.97 -99.95 - - - - - - - - - - -55.16 -19.66 -53.54 10.66
法人税等合計 - - - - - - - - - - - - - - - - - - - -28,338 -2,757 -845 -1,277 -1,752 - - - - - - - - - - - - - - - - -
実効税率(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
純利益 -9,698 -7,619 -9,349 -10,370 -10,695 -10,689 -19,475 -19,857 -25,798 -35,779 -36,308 -37,862 -44,543 -21,518 -23,134 12,281 -23,418 -34,069 -26,047 -60,054 -72,421 -58,170 -54,585 -94,483 -60,747 -175,751 -59,959 -87,000 -69,580 -83,038 -59,544 -62,421 29,276 -51,865 -26,217 -11,172 -14,489 -17,985 -8,582 -20,039 6,112
純利益率(%) - - - - - - - - - - - - - - - - - - - -
一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.51 -0.34 -0.35 0.16 -0.28 -0.14 -0.06 -0.08 -0.09 -0.04 -0.1 0.03
希薄化後一株あたり利益 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -0.51 -0.34 -0.35 0.15 -0.28 -0.14 -0.06 -0.08 -0.09 -0.04 -0.1 0.03
EBITDA - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -